TNFRSF14 aberrations in FL are associated with severe acute GVHD after AHSCT. (A) Schematic representation denoting TNFRSF14 status of purified FL B cells from lymph node biopsies from patients prior to allogeneic transplantation and occurrence of clinically significant acute GVHD (grades 2-4). Red text denotes patients whose acute GVHD was refractory to steroid therapy. (B) Cumulative incidence analysis of acute GVHD (grades 2-4) after allogeneic transplantation in FL patients with relapse/progression of lymphoma and death from other causes as competing risks. P value is for the Gray test. (C) Cumulative incidence analysis of death from acute GVHD (grades 2-4) after allogeneic transplantation in FL patients with relapse/progression of lymphoma and death from other causes as competing risks. P value is for the Gray test. NE, not evaluable.